Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-05-07 00:00:00 ET · period of report 2024-05-03 · accession 0001048477-24-000077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-07 | 2024-04-30 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | A - Grant | $68.65 | +245 | 78.6K | +0.3% | +$16.8K | |
| 2024-05-07 | 2024-05-03 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | F - Tax | $82.44 | -4,440 | 74.1K | -6% | -$366.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-30 | A | A | 245 | $68.65 | 78,572 | D | — | — | (F1) Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2024-05-03 | F | D | 4,440 | $82.44 | 74,132 | D | — | — |